Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Devon, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Zynerba Pharmaceuticals, Inc. has filed 526 SEC EDGAR filings since 09 Oct 2014

SEC filing history

Showing 376-400 of 526 matching filings.

Per page
25
Current page
16
EFFECT File 333-213430

EFFECT filing

Filing date
15 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Jun 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Jun 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Jun 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Jun 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Jun 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Jun 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37526

8-K

Filing date
09 Jun 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-218638

S-3

Filing date
09 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-213430

POS AM

Filing date
09 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37526

8-K

Filing date
08 Jun 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 May 2017
Reporting date
12 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 May 2017
Reporting date
12 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37526

8-K

Filing date
09 May 2017
Reporting date
09 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37526

8-K

Filing date
01 May 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37526

DEFA14A

Filing date
24 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37526

DEF 14A

Filing date
24 Apr 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Apr 2017
Reporting date
03 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Apr 2017
Reporting date
03 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Apr 2017
Reporting date
03 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Apr 2017
Reporting date
03 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-216968

S-8

Filing date
27 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-216967

S-8

Filing date
27 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .